Seelos Therapeutics to Present a Poster on SLS-005 in Alzheimer’s Disease at Neuroscience 2023
Seelos Therapeutics, Inc. (Nasdaq: SEEL) (“Seelos”), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it has been selected…